---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
sourceUrl: https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "JCGrL7o/4SZl7rV6gOz6ROP75JKfHWbHL6ReZoj7OsoM13oNQeN9NiK7t1ChFLrztz8kkreClsSFAJaNp2AQHrz+B6UoTW259bI7NiYHNSVYR/2x4bplQRGtNqHVySlSa0DTFiJuEcstdDsPtcqdZ1TMIYrU7wejjiDelCA+ArBouS1miWhtUCiJATq/RkNgMg63pm4aALLURA19K4e2LyZIVwAwZjlGO5eV1kM7/qAHf8pqkmmfYIl1kyOmQZsP8AzyUr2oINBAqSVszodKXL5sMIM8+fq3CQrKfimJifAT4whPsY4tlhvQEy8iHcXS;tvKfIUaPCFSYm9rRMmdqWg=="
---

